United States - English - NLM (National Library of Medicine)

chipican llc - titanium dioxide 7.0%, zinc oxide 6.0% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun

United States - English - NLM (National Library of Medicine)

solaris pharma corporation - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole vaginal gel is indicated in the treatment of bacterial vaginosis (formerly referred to as haemophilus vaginitis, gardnerella vaginitis, nonspecific vaginitis, corynebacterium vaginitis, or anaerobic vaginosis). note: for purposes of this indication, a clinical diagnosis of bacterial vaginosis is usually defined by the presence of a homogeneous vaginal discharge that (a) has a ph of greater than 4.5, (b) emits a “fishy” amine odor when mixed with a 10% koh solution, and (c) contains clue cells on microscopic examination. gram’s stain results consistent with a diagnosis of bacterial vaginosis include (a) markedly reduced or absent lactobacillus morphology, (b) predominance of gardnerella morphotype, and (c) absent or few white blood cells. other pathogens commonly associated with vulvovaginitis, e.g., trichomonas vaginalis, chlamydia trachomatis, n. gonorrhoeae, candida albicans, and herpes simplex virus should be ruled out. metronidazole vaginal gel is contraindicated in patients with a p

United States - English - NLM (National Library of Medicine)

solaris pharma corporation - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin phosphate gel, 1% is indicated in the treatment of acne vulgaris. in view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see contraindications, warnings and adverse reactions). clindamycin phosphate gel, 1% is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, a history of regional enteritis or ulcerative colitis, or a history of antibiotic-associated colitis.

United States - English - NLM (National Library of Medicine)

solaris pharma corporation - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin phosphate gel, 1% is indicated for topical application in the treatment of acne vulgaris. in view of the potential for diarrhea, bloody diarrhea, and pseudomembranous colitis, the physician should consider whether other agents are more appropriate. (see contraindications, warnings, and adverse reactions.) clindamycin phosphate gel, 1% is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, a history of regional enteritis or ulcerative colitis, or a history of antibiotic-associated colitis.

United States - English - NLM (National Library of Medicine)

solaris pharma corporation - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of neomycin sulfate tablets, usp and other antibacterial drugs, neomycin sulfate tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. neomycin sulfate tablets, usp are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel, e.g. preoperative preparation of the bowel. it is given concomitantly with erythromycin enteric-coated base (see dosage and administration section). neomycin sulfate has been shown to be effective adjunctive therapy in hepatic coma by reduction of the ammonia-forming bacteria in the intestinal tract. t

Australia - English - Department of Health (Therapeutic Goods Administration)

sanghani holdings pty ltd t/a actimed australia - 12837 - orthosis, - a device designed to support, align, prevent or correct various joint/ligament/muscular injuries or to improve the function of movable parts of the body.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanghani holdings pty ltd t/a actimed australia - 40512 - pillow, - a device designed to support or position some part of the body.the pillow consists of a casing stuffed with a variety of possible materials such as foam rubber, feathers,flock or fluid. the pillow case may be made of a variety of materials and there may be an additional outer protective covering.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanghani holdings pty ltd t/a actimed australia - 12837 - orthosis, - a device designed to support, align, prevent or correct various joint/ligament/muscular injuries or to improve the function of movable parts of the body.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanghani holdings pty ltd t/a actimed australia - 40512 - pillow, - 40512 pillow, intended purpose a device designed to support or position some part of the body.the pillow consists of a casing stuffed with a variety of possible materials such as foam rubber, feathers,flock or fluid. the pillow case may be made of a variety of materials and there may be an additional outer protective covering.

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - 37808 - probe, pulse oximeter, reusable - this device is applied to a body site, eg finger, ear, bridge of nose or foot of paediatric or adult patient, in order to transmit light through the skin to be absorbed by the oxyhaemoglobin and deoxyhaemoglobin, in the arterial tissue blood. signals are received by the parent device which displays the results. this device is reusable.